A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers
Clinical trial NCT06346184 · COMPLETED
Trial details
- NCT number
- NCT06346184
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-02
- Primary completion
- 2024-06-10
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.